Repositioning Pfizer Established Brands
Retaining market share for their established product portfolio in the face of new market and regulatory threats is vital for Pfizer. Off-patent drugs face competition from cheaper generics, so we worked with Pfizer on repositioning their products in the minds of prescribing doctors as offering better value for money than similar generic products.
Client: Pfizer Healthcare
Project: Repositioning Established Products
Audience: GPs in Ireland
